TY - JOUR
T1 - A low-fat high-carbohydrate diet supplemented with long-chain n-3 PUFA reduces the risk of the metabolic syndrome
AU - Paniagua, J. A.
AU - Pérez-Martinez, P.
AU - Gjelstad, Ingrid M.F.
AU - Tierney, Audrey C.
AU - Delgado-Lista, J.
AU - Defoort, Catherine
AU - Blaak, Ellen E.
AU - Risérus, Ulf
AU - Drevon, Christian A.
AU - Kiec-Wilk, Beata
AU - Lovegrove, Julie A.
AU - Roche, Helen M.
AU - López-Miranda, J.
N1 - Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
PY - 2011/10
Y1 - 2011/10
N2 - Objective: Dietary changes are major factor in determining cardiovascular risk. We assessed the effects of isoenergetic diets with different fat quantity and quality on the incidence and regression of the metabolic syndrome (MetS) from the LIPGENE project. Methods and design: Clinical intervention study: the patients (. n= 337) were randomly assigned to one of four diets for 12 weeks each: two high fat diets, one rich in saturated fat (HSFA) and the other rich in monounsaturated fat (HMUFA), and two low fat diets, one high in complex carbohydrates (LFHCC) supplemented with 1.24. g/day of long-chain n-3 polyunsaturated fatty acids (LFHCC n-3) and the other LFHCC diet with placebo (LFHCC). Measurements: the effects on MetS risk criteria were recorded before and after the intervention period. Results: An enlarged waist circumference (≥88. cm for women and ≥102. cm for men) was present among 95% of the participants, 88% had elevated blood pressure (>130/85. mm Hg or antihypertensive drugs), 77% had elevated fasting plasma glucose (≥5.55. mmol/L), 51% were hypertriacylglycerolemic (≥1.7. mmol/L), and 72% had low HDL cholesterol (<1.0. mmol/L for men, and <1.3. mmol/L for women). The prevalence of enlarged waist circumference, hypertension and hypertriacylglycerolemia were reduced after the LFHCC n-3 diet (. p< 0.05). Thus the prevalence of MetS fell by 20.5% after LFHCC n-3 diet compared with the HSFA (10.6%), HMUFA (12%) diet or LFHCC (10.4%) diets (. p< 0.028). Conclusions: The consumption of a low-fat high-carbohydrate supplemented with n-3 diet reduced the risk of MetS as compared with isoenergetic high-fat (HSFA and HMUFA) and LFHCC diets.
AB - Objective: Dietary changes are major factor in determining cardiovascular risk. We assessed the effects of isoenergetic diets with different fat quantity and quality on the incidence and regression of the metabolic syndrome (MetS) from the LIPGENE project. Methods and design: Clinical intervention study: the patients (. n= 337) were randomly assigned to one of four diets for 12 weeks each: two high fat diets, one rich in saturated fat (HSFA) and the other rich in monounsaturated fat (HMUFA), and two low fat diets, one high in complex carbohydrates (LFHCC) supplemented with 1.24. g/day of long-chain n-3 polyunsaturated fatty acids (LFHCC n-3) and the other LFHCC diet with placebo (LFHCC). Measurements: the effects on MetS risk criteria were recorded before and after the intervention period. Results: An enlarged waist circumference (≥88. cm for women and ≥102. cm for men) was present among 95% of the participants, 88% had elevated blood pressure (>130/85. mm Hg or antihypertensive drugs), 77% had elevated fasting plasma glucose (≥5.55. mmol/L), 51% were hypertriacylglycerolemic (≥1.7. mmol/L), and 72% had low HDL cholesterol (<1.0. mmol/L for men, and <1.3. mmol/L for women). The prevalence of enlarged waist circumference, hypertension and hypertriacylglycerolemia were reduced after the LFHCC n-3 diet (. p< 0.05). Thus the prevalence of MetS fell by 20.5% after LFHCC n-3 diet compared with the HSFA (10.6%), HMUFA (12%) diet or LFHCC (10.4%) diets (. p< 0.028). Conclusions: The consumption of a low-fat high-carbohydrate supplemented with n-3 diet reduced the risk of MetS as compared with isoenergetic high-fat (HSFA and HMUFA) and LFHCC diets.
KW - Insulin resistance
KW - Long-chain n-3 polyunsaturated effects
KW - Metabolic syndrome prevention
UR - http://www.scopus.com/inward/record.url?scp=80053233034&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2011.07.003
DO - 10.1016/j.atherosclerosis.2011.07.003
M3 - Article
C2 - 21839455
AN - SCOPUS:80053233034
SN - 0021-9150
VL - 218
SP - 443
EP - 450
JO - Atherosclerosis
JF - Atherosclerosis
IS - 2
ER -